CSE:AGN - Post Discussion
Post by
StockHawk1 on Feb 16, 2023 4:44pm
AGN.c DMT-stroke study update
Algernon Pharmaceuticals (AGN.c AGNPF) closed in the green today after sharing updates on its Phase 1 DMT Clinical Study
AGN has finished dosing the first set of patients. The safety review committee said that it is safe for AGN to carry on with the study and dose the next patient cohort
https://ca.finance.yahoo.com/news/algernon-neuroscience-provides-phase-1-120000274.html
Be the first to comment on this post